Current Stem Cell Research & Therapy

Dr. En-Qiang Chen has graduated from Sichuan University( Chengdu, China) and served as Associate professor in Center of Infectious Diseases, West China Hospital of Sichuan University. He has published more than 50 full peer reviewed publications, 8 book chapters, 15 presentations at international meetings, 2 peer reviewed funded grants and 1 authorized patent. In recent years, he has focused on the basic and clinical research of stem cells in the treatment of liver diseases.

Isotta Chimenti is Assistant Professor at the Department of Medical Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, and Junior Fellow of the Superior School for Advanced Studies at “La Sapienza” University of Rome. She is eligible as Associate Professor, according to the Italian National Scientific Qualification program. Her education includes a Master of Science in Medical Biotechnology, and a PhD in Experimental Medicine. She has been a postdoc fellow at Johns Hopkins University, at Cedars Sinai Heart Institute, and at Pasteur Institute – Italy. Her research activity is focused on regenerative medicine, in particular on cardiac cell therapy and cardiac tissue engineering, adult stem cells, and oxidative stress in the cardiovascular system. She is funded as PI by several Italian National grants, and participant in a European Horizon 2020 project. She co-authored over 55 Scopus indexed publications.

Ying-Mei Feng is a Professor at Capital Medical University in Beijing, China. Currently, she is also the deputy director of the Science and Technology Department at Capital Medical University. She received her medical degree from Tian Jin Medical University in China. After three years of residency in Neurology, she went to Belgium to pursue research. She received her Ph.D. degree in Medical Science at Leuven University in Belgium in 2008. Her main research interest is to understand the pathogenesis of vascular complications in diabetes and cardiovascular disease. She has published more than 40 papers in peer-reviewed journals including Blood, Arteriosclerosis, Thrombosis and Vascular Biology and Stem Cells. She has been on the editorial board of Plos One and Current Stem Cell Research & Therapy and served as a guest editor for Stem Cell International and Current Gene Therapy, respectively.

Yonggang Lv received the Ph.D. degree in Refrigeration and Cryogenic Engineering with specialty in bioengineering from the Technical Institute of Physics and Chemistry, Chinese Academy of Science, Beijing, in 2005. He served as a postdoctoral research associate/research fellow at the City College of the City University of New York and Memorial Sloan-Kettering Cancer Center. He joined the Bioengineering College at Chongqing University as Full Professor in March 2009 and won the Program for New Century Excellent Talents in University, Ministry of Education of China in 2010. He became a senior visiting scholar in Prof. Shu Chien’s laboratory at University of California, San Diego (UCSD) from July to October 2014. He has published over 100 peer referred journal papers, edited 3 books, and holds 9 China patents. His research interests include mechanobiology and regenerative medicine, stem cell biology, and cancer biology. Dr. Lv is the Vice Chairman of hemorheology committee in Chinese Society of Microcirculation. He is an associate editor of Medical & Biological Engineering & Computing and an editorial member of Biotechnology Letters.

Prof Junjie XIAO is the Director of Institute of Cardiovascular Sciences in Shanghai University and the Vice Dean of School of Life Sciences, Shanghai University. He is the Associate Editor of Journal of Cardiovascular Translational Research, Editorial Board of BMC Medicine, and Editorial Board of Cell Transplantation. His major research interest is heart failure, especially using exercise as a platform to identify novel targets for enhancing cardiac regeneration and combating heart failure.